Free Trial

Vertiv Holdings Co. $VRT Position Boosted by Sapient Capital LLC

Vertiv logo with Computer and Technology background

Key Points

  • Sapient Capital LLC increased its holdings in Vertiv Holdings Co. by 97.3% during the 2nd quarter, owning approximately 0.05% of the company valued at $26.7 million.
  • Vertiv reported a quarterly earnings per share (EPS) of $0.95, exceeding estimates of $0.83, with revenue of $2.64 billion, a 35.1% year-over-year increase.
  • Several analysts have recently raised their price targets for Vertiv, with Mizuho increasing it from $125 to $150 and Citigroup from $130 to $149, indicating a bullish outlook.
  • Five stocks we like better than Vertiv.

Sapient Capital LLC raised its holdings in shares of Vertiv Holdings Co. (NYSE:VRT - Free Report) by 97.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 207,999 shares of the company's stock after acquiring an additional 102,601 shares during the quarter. Sapient Capital LLC owned approximately 0.05% of Vertiv worth $26,709,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of VRT. Amundi grew its stake in Vertiv by 96.8% during the 1st quarter. Amundi now owns 6,951,773 shares of the company's stock valued at $469,490,000 after acquiring an additional 3,420,144 shares in the last quarter. 1832 Asset Management L.P. grew its stake in shares of Vertiv by 985.3% in the 1st quarter. 1832 Asset Management L.P. now owns 2,301,700 shares of the company's stock valued at $166,183,000 after buying an additional 2,089,612 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Vertiv by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 37,715,159 shares of the company's stock valued at $2,723,034,000 after buying an additional 1,359,070 shares in the last quarter. Nuveen LLC bought a new stake in shares of Vertiv in the 1st quarter valued at approximately $77,820,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Vertiv by 54.1% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,314,934 shares of the company's stock valued at $263,000,000 after buying an additional 812,389 shares in the last quarter. Hedge funds and other institutional investors own 89.92% of the company's stock.

Vertiv Trading Down 1.1%

Shares of Vertiv stock opened at $136.77 on Wednesday. The firm has a market capitalization of $52.23 billion, a PE ratio of 65.44, a price-to-earnings-growth ratio of 1.22 and a beta of 1.78. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.74 and a quick ratio of 1.35. The company's fifty day moving average price is $132.18 and its two-hundred day moving average price is $108.34. Vertiv Holdings Co. has a 52-week low of $53.60 and a 52-week high of $155.84.

Vertiv (NYSE:VRT - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.12. The firm had revenue of $2.64 billion for the quarter, compared to analyst estimates of $2.36 billion. Vertiv had a net margin of 8.93% and a return on equity of 51.64%. The business's revenue for the quarter was up 35.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.67 EPS. Vertiv has set its Q3 2025 guidance at 0.940-1.000 EPS. On average, analysts expect that Vertiv Holdings Co. will post 3.59 EPS for the current year.

Vertiv Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Monday, September 15th will be issued a $0.0375 dividend. This represents a $0.15 annualized dividend and a yield of 0.1%. The ex-dividend date of this dividend is Monday, September 15th. Vertiv's payout ratio is 7.18%.

Insider Buying and Selling at Vertiv

In other news, insider Karsten Winther sold 41,654 shares of the company's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $134.21, for a total value of $5,590,383.34. Following the sale, the insider owned 18,848 shares of the company's stock, valued at approximately $2,529,590.08. This represents a 68.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Paul Ryan sold 22,218 shares of the company's stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $127.34, for a total transaction of $2,829,240.12. Following the completion of the sale, the insider directly owned 12,803 shares in the company, valued at approximately $1,630,334.02. The trade was a 63.44% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 180,952 shares of company stock worth $23,360,571. Corporate insiders own 5.01% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on VRT. Mizuho boosted their price target on Vertiv from $125.00 to $150.00 and gave the company an "outperform" rating in a research note on Wednesday, July 16th. Oppenheimer boosted their price target on Vertiv from $140.00 to $151.00 and gave the company an "outperform" rating in a research note on Thursday, July 31st. Citigroup boosted their price target on Vertiv from $130.00 to $149.00 and gave the company a "buy" rating in a research note on Monday, July 14th. Morgan Stanley reaffirmed an "overweight" rating on shares of Vertiv in a research report on Sunday, August 10th. Finally, Wolfe Research restated an "outperform" rating and issued a $155.00 price objective on shares of Vertiv in a research note on Thursday, July 10th. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Vertiv currently has a consensus rating of "Moderate Buy" and an average target price of $142.00.

View Our Latest Report on Vertiv

Vertiv Profile

(Free Report)

Vertiv Holdings Co, together with its subsidiaries, designs, manufactures, and services critical digital infrastructure technologies and life cycle services for data centers, communication networks, and commercial and industrial environments in the Americas, the Asia Pacific, Europe, the Middle East, and Africa.

Read More

Institutional Ownership by Quarter for Vertiv (NYSE:VRT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vertiv Right Now?

Before you consider Vertiv, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vertiv wasn't on the list.

While Vertiv currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The AI-Proof Portfolio: 3 Stocks You Need to See
Markets Brace for Fed: What Investors Need to Know Before Wednesday
3 Biotech Stocks Under $5 With Huge Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines